Navigation Links
Combination antibody therapy shows promise in metastatic melanoma
Date:6/3/2011

BOSTON--A duo of drugs, each targeting a prime survival strategy of tumors, can be safely administered and are potentially more effective than either drug alone for advanced, inoperable melanomas, according to a phase 1 clinical trial led by Dana-Farber Cancer Institute investigators.

The findings (abstract 8511), will be presented in an oral session at the annual meeting of the American Society of Clinical Oncology on Saturday, June 4, 3 p.m. CT, Arie Crown Theater, McCormick Place.

The drugs -- ipilimumab and bevacizumab -- are both monoclonal antibodies, intensified formulations of natural disease-fighting proteins. Ipilimumab spurs the immune system to attack diseased cells, including tumor cells. Bevacizumab, also known by the trade name Avastin, blocks the growth of blood vessels that provide tumors with nourishment. Ipilimumab has extended the lives of metastatic melanoma patients in previous clinical trials, and bevacizumab is often used to treat tumors of the colon, lung, and kidney.

The trial involved 22 patients with metatastic melanoma that was not treatable by surgery.

F. Stephen Hodi, MD, the study's lead author and director of the melanoma treatment center at Dana-Farber, said the trial is the first to explore whether the two agents enhance each other's effectiveness. Most of the participants didn't experience serious adverse side effects, although some did experience inflammation of artery walls, the liver, thyroid gland, colon, or uvea (the middle layer of the eye). Five patients required steroid treatment for these problems and were removed the trial.

Positron emission tomography (PET) scans showed a prompt immune system response to many of the melanoma tumors, and computed tomography (CT) scans showed decreased blood flow to the tumors. Eight of the participants had partial responses -- showing some tumor shrinkage -- to the dual treatment, and six had stable disease. All the responses lasted at l
'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Combination therapy shows promise for rare, deadly cancer caused by asbestos
2. Less toxic combination of erlotinib and bevacizumab is effective non-small cell lung cancer patients
3. Model developed to improve combination vaccine accessibility worldwide
4. Gene combinations are found to be related to hip osteoporosis in postmenopausal women
5. Smoking in combination with immunosuppression poses greater risk for transplant-related carcinoma
6. Combination overcomes breast cancer resistance to herceptin
7. New combination therapy for solid tumors?
8. Certain Drug Combinations May Beat Back Aggressive Breast Cancer
9. Drug combination shows promise for newly diagnosed blood cancer patients, study finds
10. Combination therapy improves survival time for patients with advanced liver cancer
11. Best drug development results from computer/test tube combination
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... Biostimulants are widely applied in turf ... ornamentals. These also help turf and ornamentals in absorption ... Turf, ornamentals, and flowers appear healthy and strong as ... increased from the last few years. The most dominating ... Europe, with around 40% share in 2013, and is ...
(Date:7/11/2014)... Researchers from The Miriam Hospital have found that ... significantly higher rates of smoking than those without ... less likely to attempt quitting than those without ... be sufficient for this population. The study and ... print in the American Journal of Public ...
(Date:7/11/2014)... 2014 The Corn Farming ... 2014 on the heels of fresh biofuel demand. The ... dedicate a larger share of their farmland to cultivating ... regulations required the mixing of 5.0% renewable content in ... the United States created a key export market for ...
(Date:7/11/2014)... FRIDAY, July 11, 2014 (HealthDay News) -- Prostate cancer ... disease, receive less effective treatment and die sooner if ... Researchers analyzed data from more than 41,200 American men ... and 2007. They followed them through 2009. Nearly 1,900 ... the two years before their prostate cancer was discovered. ...
(Date:7/11/2014)... 11, 2014 Riverside Health System became the ... in Virginia in late 2012 and now, in partnership with ... residents throughout the Williamsburg and Newport News region. , Also ... and benefits to independent older adults who wish to remain ... safety net of continuing care services as well as control ...
Breaking Medicine News(10 mins):Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:Biostimulants Market in Turf and Ornamentals is Expected to Reach $ 3.8 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:Miriam Hospital study examines smoking prevalence 2Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 2Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 3Health News:Depression May Make It Harder to Beat Prostate Cancer 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 3Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 4
... in Care, The experience of Ontario, Canada ... inequities but not education-related disparities in health care ... data on more than 25,558 residents of Ontario, ... covered by government, researchers find patient income levels ...
... related to heart disease, study shows , MONDAY, Sept. 21 ... at higher risk for having a heart attack, especially those ... both seasonal and the pandemic H1N1 swine flu are circulating ... are urged to get a seasonal flu shot and an ...
... of a specific gene variant shows a strong ... (UC) have demonstrated. In addition, the research indicates ... individuals harboring the gene variant can be further ... Stambrook, PhD, a professor in the department of ...
... , , SACRAMENTO, Calif., ... the Twin Rivers Unified School District will be able to ... created jointly by the California Dental Association Foundation, University of ... California HealthCare Foundation with start-up funding from Verizon. , ...
... 21 HTH Worldwide, a global health and safety ... are now available with sickness, accident and medical evacuation ... that include direct payment to participating doctors and hospitals ... the market today limit medical benefits to $25,000 or ...
... MARINA DEL REY, Calif., Sept. 21 Electronic medical records have ... Dr. Richard Merkin, CEO for Heritage Provider Network. HPN and its ... York have been eliminating waste and cutting costs while providing quality ... on the importance of integrating electronic medical records. , , ...
Cached Medicine News:Health News:September/October 2009 Annals of Family Medicine tip sheet 2Health News:September/October 2009 Annals of Family Medicine tip sheet 3Health News:September/October 2009 Annals of Family Medicine tip sheet 4Health News:September/October 2009 Annals of Family Medicine tip sheet 5Health News:September/October 2009 Annals of Family Medicine tip sheet 6Health News:Flu Can Raise Chances of Heart Attack 2Health News:Flu Can Raise Chances of Heart Attack 3Health News:Cancer predisposition from genetic variation shows strong gender bias 2Health News:New Tele-Health Care Project to Provide Dental Care to Underserved Communities in California 2Health News:New Tele-Health Care Project to Provide Dental Care to Underserved Communities in California 3Health News:New Tele-Health Care Project to Provide Dental Care to Underserved Communities in California 4Health News:HTH Worldwide Introduces Trip Protection Insurance With Major Medical Benefits 2Health News:Heritage Provider Network and Dr. Richard Merkin Highlight Cutting Health Care Costs Using Electronic Medical Records 2
(Date:7/10/2014)... , July 10, 2014  BC Technical, the largest ... MiE America , Inc., a leading provider of Siemens ... a long-term agreement naming BC Technical as the authorized ... MiE and BC Technical announced today that ... establish BC Technical as the service and systems provider ...
(Date:7/10/2014)... CVS Caremark Corporation (NYSE: CVS ) today announced ... of $0.275 (27.5 cents) per share on the corporation,s common ... holders of record on July 21, 2014. About ... helping people on their path to better health as the ... . Through the company,s more than 7,600 CVS/pharmacy stores; ...
(Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ... Consumables Market - Global Industry Analysis, Size, Share, Growth, ... their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ... are used on patients in order to treat dental ...
Breaking Medicine Technology:BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3
... COTTAGE, N.Y., June 30 XTL,Biopharmaceuticals Ltd. (Nasdaq: ... patient randomization into its Phase 2b study of Bicifadine,-- ... the,treatment of diabetic neuropathic pain. 350 patients were randomized ... Company expects to,have the last patient complete the study ...
... new understanding of,the role played by the protein ... novel therapies to rebuild muscle tissue,damaged by disease, ... Institute for Cancer Research and Molecular Medicine at ... The researchers reported their findings, "Cdk9-55: A ...
Cached Medicine Technology:XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain 2XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain 3International Team Locates Key Player in Muscle Regeneration 2
... meridianEMR is a revolutionary "blended model ... patient medical records in your office and ... team of physicians and software engineers, meridianEMR ... to create a highly modular medical EMR ...
... OB/GYN, ER/Trauma, ICC/CCU, woundcare and burn ... precision and control, plus consistent high ... SATIN PLUS* Sterile Singles deliver all ... provides excellent tactile sensitivity. The gloves ...
... Polymed has become even better. Polymed® TLC latex ... Polymed with the exciting addition of vitamin E. ... which are vital to healthy skin. Polymed TLC ... reduce the potential for latex sensitization. The lightly ...
... Clear View Drapes allow practitioners ... patient's leg during intraoperative adjustments. Makes ... and access legholder adjustment handles for ... tear even when controls are adjusted ...
Medicine Products: